The DOI matches its Crossref record.
Prevalence of Alzheimer's Disease in a Community Population of Older Persons: Higher Than Previously Reported
Abstract
Clinically diagnosed Alzheimer's disease and other dementing illnesses were assessed in a geographically defined US community. Of 3623 persons (80.8% of all community residents over 65 years of age) who had brief memory testing in their homes, a stratified sample of 467 persons underwent neurological, neuropsychological, and laboratory examination. Prevalence rates of Alzheimer's disease were calculated for the community population from the sample undergoing clinical evaluation. Of those over the age of 65 years, an estimated 10.3% (95% confidence limits, 8.1% and 12.5%) had probable Alzheimer's disease. This prevalence rate was strongly associated with age. Of those 65 to 74 years old, 3.0% (95% confidence limits, 0.8 and 5.2) had probable Alzheimer's disease, compared with 18.7% (95% confidence limits, 13.2 and 24.2) of those 75 to 84 years old and 47.2% (95% confidence limits, 37.0 and 63.2) of those over 85 years. Other dementing conditions were uncommon. Of community residents with moderate or severe cognitive impairment, 84.1% had clinically diagnosed Alzheimer's disease as the only probable diagnosis. These data suggest that clinically diagnosed Alzheimer's disease is a common condition and that its public health impact will continue to increase with increasing longevity of the population. (JAMA. 1989;262:2551-2556)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on studies that show clinical AD [6, 8], MCI [88], and preclinical AD [67] are common in the elderly, by this scheme that vast majority of those past the age of 85 have AD (Figure 2).”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [6]
Citations
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Driving Cessation and Alternative Community Mobility
Eby, D. W., Molnar, L. J., & Pellerito, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-032302937-7.50027-7 · Cited by 7
Construction of mouse brain MRI templates using SPM 99
Lin, L., Chen, K., Alexander, G. E., He, J., Valla, J. E., Galons, J., Hauss‐Wegrzyniak, B., & Reiman, E. M. (2003) · IFAC Proceedings Volumes · doi:10.1016/s1474-6670(17)33484-5 · Cited by 6
The Intersection of Strategy and Drug Research
Moos, W. H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00033-x · Cited by 10
La maladie d’Alzheimer, d’une création nosographique à une logique de prévention
Pringault, S. (2018) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2017.12.005 · Cited by 8
Management of Patients with Alzheimer's Disease
Odenheimer, G. L. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb02633.x · Cited by 6
Relationship of plaques and tangles to Alzheimer's disease phenotype
Morris, J. C. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50013-3 · Cited by 6
Molekulare Medizin der Alzheimer-Krankheit
Hoyer, S., Frölich, L., & Sandbrink, R. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_7 · Cited by 6
Comorbidity of Dementia and Psychiatric Disorders in Older Persons
Rummans, T. A., Smith, G. E., Lin, S.-C., et al. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700530-00011 · Cited by 6
Ormrod, D. J., & Spencer, C. M. (2000) · CNS Drugs · doi:10.2165/00023210-200013060-00006 · Cited by 6
Alzheimer-type of pathological changes in Chinese
Ng, H., Cheng, Y., & Poon, W. S. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00253-5 · Cited by 7
Geriatric Psychiatry Fellowship Recruitment: Crisis or Opportunity?
Small, G. W. (1993) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199300110-00009 · Cited by 6
Might Cortical Hyper-Responsiveness in Aging Contribute to Alzheimer’s Disease?
Jacob, M., & Duffy, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105962 · Cited by 5
Technological innovations for individuals with Alzheimer's disease
Fernie, G. R., & Femnie, B. (1990) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759000500304 · Cited by 6
Managing Alzheimer Dementia Tomorrow
Rosenthal, T. C., & Khotianov, N. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.5.423 · Cited by 7
Synthesis and Biological Evaluation of Analogues of a Novel Inhibitor of β-Amyloid Secretion
Chakrabarti, E., Ghosh, S. K., Sadhukhan, S., Sayre, L. M., Tochtrop, G. P., & Smith, J. D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100308g · Cited by 6
New access to Alzheimer’s and other neurodegenerative diseases
Hamacher, M., Meyer, H. E., & Marcus, K. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.5.591 · Cited by 6
Partial characterization of apoptotic factor in Alzheimer plasma
Maesaka, J. K., Palaia, T. A., Chowdhury, S. A., Shimamura, T., Fishbane, S., Reichman, W. E., Coyne, A. C., O’Rear, J. J., & El-Sabban, M. E. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.4.f521 · Cited by 6
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Sisodia, S. S., Martin, L. J., Walker, L. C., Borchelt, D., & Price, D. L. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00276-x · Cited by 6
Hendrie, H. C., Unverzagt, F. W., & Austrom, M. G. (1997) · Psychiatric Quarterly · doi:10.1023/a:1025488324153 · Cited by 6
“with the prevalence rate approximately doubling every five years after age 65, rising to more than 30% in patients 85 years of age and over.(2,3,4,5) If milder forms of the syndrome are included,”
BackgroundStatins for the treatment of Alzheimer's disease and dementia
McGuinness, B., Bullock, R. A., Craig, D., Kerr, E., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514 · Cited by 7
Clinical Aspects of Alzheimer's Disease
Knopman, D. S. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch8 · Cited by 8
Molinari, V., & Hartman-Stein, P. E. (2000) · Clinical Psychology Science and Practice · doi:10.1093/clipsy.7.3.312 · Cited by 6
Availability of special nursing home programs for Alzheimer's disease patients
Leon, J., Potter, D. E. B., & Cunningham, P. J. (1991) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759100600102 · Cited by 6
Miller, D. K., & Kaiser, F. E. (1993) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30420-8 · Cited by 6
Assistive Devices, Robotics, and Quality of Life in the Frail Elderly
Fernie, G. R. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-101275-5.50011-9 · Cited by 6
Managing Pain in the Institutionalized Elderly
Wells, N. L., Kaas, M. J., & Feldt, K. S. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0283-2_6 · Cited by 6
Qian, M., Zhang, N., Zhang, R., Liu, M., Wu, Y., Lu, Y., Li, F., & Zheng, L. (2024) · Nutrients · doi:10.3390/nu16162774 · Cited by 6
“The number of people aged 65 years and older is believed to be going to increase to 19.3% by 2030, and about 1% of people will suffer from dementia at the age of 60 [2].”
BackgroundInfluentialWartchow, K. M., Rodrigues, L., Dartora, W. J., Biasibetti, R., Selistre, N. G., Lazarian, A., Castellanos, C. B., Bartelo, N., Gonçalves, C., McIntire, L. B., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104810 · Cited by 5
“While age is considered the main risk factor [14,15], there are other potential risks such as hypertension, cholesterol/apolipoprotein alleles, head trauma, inflammation, environmental, and metabolic (diabetes), more specifically glucose and insulin [16].”
Yakemow, G., Kolesar, T. A., Wright, N., Beheshti, I., Choi, E. H., Ryner, L. N., Chaulk, S. J., Patel, R., & Ko, J. H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1470727 · Cited by 5
The first 25 years of the Northwestern University SuperAging Program
Weıntraub, S., Gefen, T. D., Geula, C., & Mesulam, M. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70312 · Cited by 8
Genetics of Alzheimer's disease
Papassotiropoulos, A., Hock, C., Streffer, R., & Nitsch, M. (2001) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2001.01243 · Cited by 5
Neuronal cell death in human neurodegenerative diseases and their animal/cell models
Martin, L. J., Liu, Z., Troncoso, J. C., & Price, D. L. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663543.005 · Cited by 5
Longobardi, P. G., Cummings, J. L., & Anderson‐Hanley, C. (2000) · Critical issues in neuropsychology · doi:10.1007/978-1-4615-4219-3_9 · Cited by 5
Editor's note: The parameters of adult development
Demick, J. (1994) · Journal of Adult Development · doi:10.1007/bf02252977 · Cited by 5
Neuropsychology in the Diagnosis and Treatment of Dementia
Sewell, M. C., Vigario, A., & Sano, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6231-8.10053-4 · Cited by 5
Pai, V., Chandrashekar, K. S., Pai, A., et al. (2021) · RASAYAN Journal of Chemistry · doi:10.31788/rjc.2021.1456602 · Cited by 5
Effective Diagnosis of Alzheimer’s Disease by Means of Distance Metric Learning and Random Forest
Chaves, R., Ramı́rez, J., Górriz, J. M., Illán, I., Segovia, F., & Olivares, A. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-21326-7_7 · Cited by 5
Supporting strengths and responding to agitation in dementia care: An exploratory study
Taft, L. B., Matthiesen, V., Farran, C. J., et al. (1997) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759701200503 · Cited by 5
Potential βPP-processing proteinase activities from alzheimer's and control brain tissues
Ladror, U. S., Wang, G. T., Klein, W. L., Holzman, T. F., & Krafft, G. A. (1994) · Journal of Protein Chemistry · doi:10.1007/bf01901691 · Cited by 5
Emotional withdrawal, CT abnormalities and drug response in late life depression
Altamura, A. C., Bassetti, R., Santini, A., et al. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.014 · Cited by 5
Assessing cognitive impairment in older people: the Watson clock drawing test
Esther, C. A., Hagen, B. F., Sandilands, M. L., et al. (2004) · British Journal of Community Nursing · doi:10.12968/bjcn.2004.9.8.15359 · Cited by 5
Alcohol Abuse and Alzheimer's Disease
Larkin, J. P., & Seltzer, B. (1994) · Psychiatric Services · doi:10.1176/ps.45.10.1040 · Cited by 5
Approaches to the Office Care of the Older Adult and the Specter of Dementia
Lawhorne, L. W., & Ogle, K. S. (2005) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2005.06.013 · Cited by 5
“Incidence doubles every 5 years starting at age 65 years, with up to 50% of those over age 85 years developing some type of dementia [20,22].”
BackgroundKolowski, S., & Rossiter, J. (2000) · Psychiatric Bulletin · doi:10.1192/pb.24.8.304 · Cited by 5
Effects of besipirdine at the voltage‐dependent sodium channel
Tang, L., Smith, C. P., Huger, F. P., et al. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15097.x · Cited by 5
Neuropsychology of Aging and Dementia
Koss, E. (1994) · Elsevier eBooks · doi:10.1016/b978-0-08-092668-1.50017-x · Cited by 5
The epidemiology of dementia in North America
Eastwood, M. R., Rifat, S. L., & Roberts, D. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189528 · Cited by 5
Automobile driving and Alzheimer's disease
Shemon, K., & Christensen, R. C. (1991) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759100600502 · Cited by 5
Salzman, C., & Nevis-Olesen, J. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-101277-9.50030-9 · Cited by 7
Treatment of Depression in Patients with Dementia
Fridman, E. A., & STARKSTEIN, S. E. (2000) · CNS Drugs · doi:10.2165/00023210-200014030-00002 · Cited by 5
The Effect of Femented Platycodon grandiflorum on the Memory Impairment of Mice
Kim, T.-Y., & Shin, Y.-W. (2013) · The Korea Journal of Herbology · doi:10.6116/kjh.2013.28.2.25 · Cited by 4
Valle, R., Garrett, M. D., & Velasquez, R. (2013) · Journal of Population Ageing · doi:10.1007/s12062-013-9084-1 · Cited by 4
“U.S. national ADAD prevalence data relies heavily on the 2007 study by Plassman et al. (2007), which updated the 1989 study by Evans et al. (1989).”
BackgroundMethodAlzheimer’s Disease: An Epidemiologic Disaster From Nutritional Perspective
Péter, S. (2017) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2017.00184 · Cited by 4
The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
Serrano, E., Sanz, P. G., & Barrantes, F. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_29 · Cited by 4
Cognitive impairment and pain relief following hip fractures: a case control study
Aftab, R., Dixit, D., Williams, S., et al. (2021) · British Journal of Pain · doi:10.1177/20494637211041146 · Cited by 4
Deciphering the focal role of endostatin in Alzheimer’s disease
Kaur, D., Behl, T., Chigurupati, S., Sehgal, A., Singh, S., Sharma, N., Badavath, V. N., Vargas-De-La-Cruz, C. B., Bhatia, S., Al‐Harrasi, A., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16567-7 · Cited by 4
“Themaximum number of AD cases has been outlined among individuals belonging to or above the 65-year age group (Evans et al. 1989; Lyketsos et al. 1997).”
BackgroundThe Validity of Cognitive Testing in Screening for Dementia
Stockton, P., Cohen‐Mansfield, J., & Billig, N. (1998) · Journal of Medical Systems · doi:10.1023/a:1022602421947 · Cited by 4
“tion of norms to reduce the rate of "false positives" in screening studies for dementia and/or delirium, a rate which in one widely cited investigation was 39%.(14) However, in a later study, funded in part by the NIMH, the MMSE and other screening tests were administered to a large sample of elderly people in Shangha…”
BackgroundMethodResultDeKosky, S. T., & López, O. L. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70053-x · Cited by 5
Lilienfeld, S., & Kurz, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04855.x · Cited by 4
Dementia and Alzheimer's Disease: A Practical Orientation
Abraham, I. L. (2006) · Nursing Clinics of North America · doi:10.1016/j.cnur.2005.10.001 · Cited by 4
“The epidemiology of AD remains somewhat contested [8], mainly because of differences in study methodologies; however, as a rule of thumb, one can assume that 10% of the population that is 65 years of age and older may suffer from AD—about 5% of those between 65 and 74 years old, almost 20% of those between 75 and 84 y…”
BackgroundLONGITUDINAL FOLLOW-UP OF LATE-ONSET ALZHEIMER DISEASE FAMILIES
Carney, R., Slifer, M. A., Lin, P., Gaskell, P., Scott, W., Potocky, C., Hulette, C., Welsh-Bohmer, K., Schmechel, D., Vance, J., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30590 · Cited by 5
“The prevalence of AD for those 65 years of age or greater is 10.3% [Evans et al., 1989].”
BackgroundInfluentialUn nouveau regard sur les maladies neurodégénératives
Christen, Y. (2001) · Gérontologie et société · doi:10.3917/gs.097.0063 · Cited by 4
Inside SMP proteomics: Six years German Human Brain Proteome Project (HBPP) – A summary
Hamacher, M., Hardt, T., van Hall, A., et al. (2008) · PROTEOMICS · doi:10.1002/pmic.200700980 · Cited by 4
Completion of a Durable Power of Attorney for Health Care: What Does Cognition Have to Do With It?
McGuire, L. C., Rao, J. K., Anderson, L. A., & Ford, E. S. (2007) · The Gerontologist · doi:10.1093/geront/47.4.457 · Cited by 4
“The Gerontologist Copyright 2007 by The Gerontological Society of America Vol. 47, No. 4, 457–467”
BackgroundPreventive health care for older patients
Parks, S. M., & Hsieh, C. (2002) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(02)00005-2 · Cited by 4
HORMONE REPLACEMENT FOR THE NEW MILLENNIUM
Gass, M. L. S., & Rebar, R. W. (2000) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70159-5 · Cited by 4
Sabat, S. R. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714.033 · Cited by 4
Late-Life Marriages, Older Stepfamilies, and Alzheimer's Disease
Kuhn, D. R., Morhardt, D., & Monbrod-Framburg, G. (1993) · Families in Society The Journal of Contemporary Social Services · doi:10.1177/104438949307400303 · Cited by 4
4. Diagnosing Dementia: Epidemiological and Clinical Data as Cultural Text
Graham, J. (2020) · Rutgers University Press eBooks · doi:10.36019/9780813539270-006 · Cited by 4
Selective Cholinergic Neurotoxins
Walsh, T. J., & Potter, P. E. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1_12 · Cited by 4
Brain Protein Oxidation and Modification for Good or for Bad in Alzheimer’s Disease
Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_17 · Cited by 4
Patterns of syphilis testing in the elderly
Naughton, B. J., & Moran, M. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02598082 · Cited by 4
Substrate interaction inhibits γ-secretase production of amyloid-β peptides
Zhao, J., Xiao, Y., Liu, X., Kim, S., Wu, X., Barros, M., Zhuang, R., Hou, X., Zhang, Y., Robakis, N. K. R. K., et al. (2020) · Chemical Communications · doi:10.1039/c9cc09170j · Cited by 4
Nutrition and End-of-Life Care
Furman, C. D., & Ritchie, C. S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-391-0_14 · Cited by 4
When family caregivers grieve for the Alzheimer's patient
Curl, A. (1992) · Geriatric Nursing · doi:10.1016/s0197-4572(05)80375-1 · Cited by 4
Methodological Aspects of Comparative Research in the Epidemiology of Alzheimer Disease
de Figueiredo, J. M. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200207000-00004 · Cited by 5
Applications of Analytical Ultracentrifugation in Structure-Based Drug Design
Holzman, T. F., & Snyder, S. W. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6828-1_16 · Cited by 4
Luchsinger, J. A. (2010) · Research and Perspectives in Alzheimer's Disease · doi:10.1007/978-3-642-04300-0_7 · Cited by 3
Detection of Cognitive Impairment From eSAGE Metadata Using Machine Learning
Kawakami, R., Wright, K., Scharre, D. W., & Ning, X. (2023) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000593 · Cited by 3
Gareri, P., Cotroneo, A. M., Gelmini, G., Mossello, E., Massaia, M., The Touch Working Group, Bartalucci, F., Bellintani, L., Cerracchio, E., Corsi, M., et al. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02749-z · Cited by 3
“The prevalence of Alzheimer’s disease (AD) has been increasing in recent years and we expect to go from the about 5.8 million Americans aged 65 years and older in 2020 (80% out of them aged 75 years old or older) [1] up to 13.8 million individuals in 2050 [2].”
BackgroundInfluentialB‐type natriuretic peptide and severity of cognitive disorder
Hiltunen, M., Nieminen, T. V. M., Kettunen, R., Hartikainen, S. A., Sulkava, R. O., Vuolteenaho, O. J., & Kerola, T. V. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12160 · Cited by 3
Study on Correlation between Cognitive Impairment and Geriatric Depression or Geriatric Stress
Kim, D. J., Cho, S., Choi, J. S., et al. (2019) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2019.51.1.105 · Cited by 3
“경질환인 알츠하이머성 치매(Alzheimer’s disease, AD)로 전 체 치매의 절반 이상을 차지하고[2, 3], 다양한 뇌혈관 질환으로”
Chapter 28 Clinical approaches to dementia
McKhann, G. M. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61963-9 · Cited by 3
Genetics of Alzheimer's Disease
Honig, L. S. (1997) · Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders · doi:10.1044/nnsld7.4.6 · Cited by 3
Carmien, S., Cavallaro, F. I., & Koene, R. A. (2009) · International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) · doi:10.1145/1579114.1579158 · Cited by 3
The Impact of Alzheimer Disease Genetics on Expert and Advanced Gerontological Nursing Practice
Schutte, D. L. (1998) · AACN Clinical Issues Advanced Practice in Acute & Critical Care · doi:10.1097/00044067-199811000-00006 · Cited by 4
Shibayama, H., Kobayashi, H., Nakagawa, M., et al. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00022.x · Cited by 3
Effects of Aging on the Human Nervous System
de la Torre, J. C., & Fay, L. A. (2001) · Springer eBooks · doi:10.1007/978-1-4757-3432-4_64 · Cited by 3
Medial Temporal Atrophy as a Magnetic Resonance Imaging Marker for Alzheimer's Disease
Barclay, L., Linden, C. N., & Murtagh, R. F. (1992) · Journal of Neuroimaging · doi:10.1111/jon199223131 · Cited by 3
Pavlou, D., Beratis, I., Fragkiadaki, S., Kontaxopoulou, D., Yannis, G., Economou, A., & Papageorgiou, S. G. (2017) · Transportation research procedia · doi:10.1016/j.trpro.2017.05.300 · Cited by 3
The Mental Health of Culturally Diverse Older Adults
Black, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394420-7.00021-7 · Cited by 3
Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
Sharma, P., Gaur, V. K., & Srivastava, J. K. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_10 · Cited by 3
Brewer, J. B., Gabrieli, J. D. E., Preston, A. R., Vaidya, C. J., & Rosen, A. C. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10005-0 · Cited by 3
Reiman, E. M., Caselli, R. J., Chen, K., & Alexander, G. E. (2004) · Springer eBooks · doi:10.1007/978-3-642-59300-0_12 · Cited by 3
The Pharmacotherapy of Human Aggression: A Review
Caley, C. F. (1996) · Journal of Pharmacy Practice · doi:10.1177/089719009600900210 · Cited by 3
Communicating effectively with elderly surgical patients
moore, L. W., Moore, L. W., & Proffitt, C. (1993) · AORN Journal · doi:10.1016/s0001-2092(07)65240-5 · Cited by 3
Age-Related Changes in Subcortical Nuclei that Project to the Cerebral Cortex
Kemper, T. L. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_10 · Cited by 3
MANDATORY COGNITIVE SCREENING IN HOSPITALIZED ELDERLY PEOPLE: ARE WE MISSING THE DIAGNOSIS?
Chang, E. T., Jacoby, S. H., Wang, J., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02204.x · Cited by 3
“Based on known prevalence of dementia in older adults, the retrospective group of uncommunicative patients included a large number of patients with dementia, even though it would not be possible to screen those patients because of obvious clinical barriers.(5) Therefore, the rate of documented dementia in the retrospe…”
BackgroundTreatment Development Strategies for Alzheimer's Disease
Wülfert, E. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00300.x · Cited by 3
Metadata
- Authors
- Evans, D. A.
- Corresponding author
- Evans, Denis A.
- ORCID
- Evans, Denis A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1989-11-10
- Volume
- 262
- Issue
- 18
- Pages
- 2551
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2129678592
- Cited by
- 1,226
- References
- 0
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 15 · 2022: 9 · 2021: 20 · 2020: 22 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 28 · 2015: 23 · 2014: 17 · 2013: 32 · 2012: 25
- FWCI
- 44.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institute on Aging (N01-AG02107, N01‐AG‐1‐2106, AG 06789)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- Alzheimer's disease, prevalence, older adults, dementia, age-related cognitive decline, community-dwelling older adults, cognitive impairment, age differences in prevalence, public health impact
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
